brand

Asia Pacific Carcinoembryonic Antigen Market Size & Outlook

The carcinoembryonic antigen market in Asia Pacific is expected to reach a projected revenue of US$ 713.1 million by 2030. A compound annual growth rate of 7% is expected of Asia Pacific carcinoembryonic antigen market from 2024 to 2030.

Revenue, 2023 (US$M)
$445.5
Forecast, 2030 (US$M)
$713.1
CAGR, 2024 - 2030
7%
Report Coverage
Asia Pacific

Asia Pacific carcinoembryonic antigen market, 2018-2030 (US$M)

  • Select file type
Asia

Related Markets

Global Carcinoembryonic Antigen Industry Outlook

North America Carcinoembryonic Antigen Market Outlook

Europe Carcinoembryonic Antigen Market Outlook

Latin America Carcinoembryonic Antigen Market Outlook

MEA Carcinoembryonic Antigen Market Outlook

Asia Pacific carcinoembryonic antigen market highlights

  • The Asia Pacific carcinoembryonic antigen market generated a revenue of USD 445.5 million in 2023.
  • The market is expected to grow at a CAGR of 7% from 2024 to 2030.
  • In terms of segment, colorectal cancer was the largest revenue generating type in 2023.
  • Colorectal Cancer is the most lucrative type segment registering the fastest growth during the forecast period.


Asia Pacific data book summary

Market revenue in 2023USD 445.5 million
Market revenue in 2030USD 713.1 million
Growth rate7% (CAGR from 2023 to 2030)
Largest segmentColorectal cancer
Fastest growing segmentColorectal Cancer
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationColorectal Cancer


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.7% of the global carcinoembryonic antigen market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 713.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Carcinoembryonic Antigen Market Scope

Carcinoembryonic antigen market segmentation & scope
Type
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Gender
Male
Female
Product
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Test
Molecular Tests
Serology Tests
End-use
Hospitals
Laboratories
Others
Regions
Latin America
Europe
North America
Middle East & Africa
Asia Pacific
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Carcinoembryonic Antigen Market Companies

Name Profile # Employees HQ Website

Asia Pacific carcinoembryonic antigen market

  • Select file type
Asia Unlock Premium

Related industry reports

Global Spatial OMICS Market Outlook, 2023-2030

Global Protein Labeling Market Outlook, 2023-2030

Global Protein Purification And Isolation Market Outlook, 2023-2030

Global Transfer Membrane Market Outlook, 2023-2030

Global Protein Crystallization Market Outlook, 2023-2030

Related regional statistics

North America adult stem cell market statistics, by type, 2018-2030 (US$M)

North America human embryonic stem cells market statistics, by application, 2018-2030 (US$M)

North America very small embryonic like stem cells market statistics, by application, 2018-2030 (US$M)

Latin America monoclonal antibodies market statistics, by country 2018-2030 (US$M)

Latin America polyclonal antibodies market statistics, by country 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more